Yet both clinical experience and new research show wide variation in how people respond
Like GLP-1, GIP stimulates insulin secretion from pancreatic cells in a glucose-dependent manner ( Research on obese mice suggests that unimolecular poly-pharmacology is an effective means to deal with various mechanisms leading to obesity and further indicates that GCGR activation is the distinguishing factor between single or double agonists and triple agonists of incretin receptors ( GLP-1R agonists improve glucose homeostasis in patients with T2DM, cause weight loss, and benefit cardiovascular health over time
By targeting glucagon, retatrutide may help the body access and use stored energy more efficiently, while the targeted GLP-1 and GIP hormones help support fullness, appetite control, and blood sugar regulation
Following guidance from your healthcare provider and slowly increasing your dose could help to reduce these side effects
GLP-1 medications are protein-based biologics susceptible to degradation from temperature extremes, requiring refrigeration between 2C and 8C before opening
